Openspace Ventures and EDBI led a USD10m Series A for Neuroglee Therapeutics, a Singapore-based startup developing digital therapeutics for people with neurodegenerative diseases, with participation from Ramen Singh (Mundipharma) and Kuldeep Singh Rajput and Wendou Liu (Biofourmis), and follow-on from Japanese healthcare company Eisai. Read more